Literature DB >> 2228501

Combined peritoneal and haemodialysis therapy for chronic renal insufficiency.

A Karátson1, J Makó, G Szöllösi, G Boros, I Solt, M Méhes, H Brasch, J Sámik.   

Abstract

Twenty-three patients with chronic uraemia were treated for an average of 8.5 months with intermittent peritoneal dialysis. When hypervolaemia developed and/or the volume of low-molecular weight substances increased, the therapy was complemented by one or two sessions of haemodialysis per week. The combined treatment was carried on for 4.1 months on average, in consequence of which the general condition improved, body weight reached the optimum, blood pressure diminished, turned normal and could be controlled by drugs. In the wake of the therapy carbamide nitrogen and creatinine levels dropped significantly, serum total protein and albumin values increased. At the close of the observation period 3 patients remained under combined therapy, 2 had undergone cadaveric kidney transplantation, 18 were transferred to chronic haemodialysis. Thoughts are evolved about the advisability of intermittent peritoneal dialysis and combined therapy in the care for uraemic patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2228501     DOI: 10.1007/bf02549800

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  18 in total

1.  Long-term CAPD--some U.K. experience.

Authors:  R Ataman; P R Burton; R Gokal; C B Brown; F P Marsh; J Walls
Journal:  Clin Nephrol       Date:  1988       Impact factor: 0.975

Review 2.  Comparison of continuous ambulatory peritoneal dialysis and hemodialysis.

Authors:  K D Nolph
Journal:  Kidney Int Suppl       Date:  1988-03       Impact factor: 10.545

3.  Effect of hyperosmolar peritoneal dialysis fluid on the elimination of small- and medium-molecular substances.

Authors:  A Karátson; J Gróf; L Gofman; L Rácz
Journal:  Int Urol Nephrol       Date:  1983       Impact factor: 2.370

4.  [Effectiveness of chronic peritoneal dialysis].

Authors:  E A Balás
Journal:  Orv Hetil       Date:  1981-08-02       Impact factor: 0.540

5.  Amyloid, carpal tunnel syndrome, and chronic hemodialysis.

Authors:  A E Walts; M D Goodman; P A Matorin
Journal:  Am J Nephrol       Date:  1985       Impact factor: 3.754

6.  Satellite peritoneal dialysis.

Authors:  A Karátson; P Ablonczy; L Farkas; D Frang; F Gregorits; A Hámori; G Kosik; I Megyeri; L Német; I Tétényi
Journal:  Int Urol Nephrol       Date:  1980       Impact factor: 2.370

7.  [Changes in laboratory chemical values during continuous peritoneal dialysis].

Authors:  A Karátson; N Jung; H Thieler; J Gróf; D Frang
Journal:  Orv Hetil       Date:  1980-10-26       Impact factor: 0.540

8.  Fate of parathyroid hormone during hemodialysis and ultrafiltration.

Authors:  P Burckhardt; P Jaeger; A F Jacquet; J P Wauters
Journal:  Horm Res       Date:  1985

9.  Case-control study to determine the cause of sclerosing peritoneal disease.

Authors:  R Oulès; S Challah; F P Brunner
Journal:  Nephrol Dial Transplant       Date:  1988       Impact factor: 5.992

10.  Longitudinal comparison of intermittent versus continuous ambulatory peritoneal dialysis, in the same patients.

Authors:  M A Madden; S W Zimmerman; D P Simpson
Journal:  Clin Nephrol       Date:  1981-12       Impact factor: 0.975

View more
  1 in total

1.  Peritoneal dialysis in Hungary.

Authors:  A Karátson; J Makó
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.